Wockhardt Ltd
- All
- News
- Videos
-
Wockhardt's Ex-Executive Barred From Securities Market For 6-Months For Insider Trading
Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules.
-
Wockhardt Reports Rs 207 Crore Loss In Q2 After Restructuring Its US Business
Wockhardt Ltd on Friday reported a consolidated loss after tax of Rs 207 crore in the second quarter ended September 30, 2022
-
UK Extends COVID-19 Vaccine Supply Deal With India's Wockhardt: Report
The United Kingdom has extended a deal with Wockhardt Ltd for the supply of COVID-19 vaccines by six months, the drugmaker said on Wednesday.
-
Wockhardt To Supply Millions Of Doses Of COVID-19 Vaccines To UK
Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Surges 5% As US Drug Regulator Excludes Drug From Import Alert
Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.
-
Expanding Markets, Launching New Products For Growth: Wockhardt
Wockhardt Ltd has said it is increasing investments in R&D, looking at expanding markets and launching new products to accelerate growth.
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal
The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.
-
Finance Ministry Looks To Expedite Clearances To FDI Proposals
Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).
-
Wockhardt Posts Over 82% Fall in Q3 Profit
Pharmaceuticals major WockhardtLtd on Thursday reported an 82.44 per cent decline in consolidatednet profit at Rs 60.97 crore for the fiscal third quarter that ended onDecember 31, 2015.
-
Wockhardt Slumps After US Regulator's Criticism of New Drug Plant
Drug maker Wockhardt Ltd said the US Food and Drug Administration (FDA) had issued a notice outlining manufacturing violations at its Shendra plant in western India, delaying the company's plans to rebuild its battered US business.
-
Allegiant Health Recalls Wockhardt's Heartburn Drug in US
According to the Enforcement Report for the week of June 24, 2015, the US health regulator has said 86,106 cartons of over-the-counter (OTC) Famotidine tablets USP of 20 mg are being voluntarily recalled by Allegiant Health.
-
Wockhardt to Recall Some India-Made Drugs Post-FDA Concerns
Generic drug maker Wockhardt Ltd on Tuesday said it would recall some drugs manufactured at its two plants in India before the US Food and Drug Administration (FDA) banned those sites due to quality concerns.
-
US Regulator Found No Issues With Maharashtra Plant: Wockhardt
Drug maker Wockhardt Ltd on Wednesday said the US Food and Drug Administration (FDA) has not found any issues with respect to data security and control measures at Chikalthana plant in a recent inspection, but suggested continuous voluntary compliance for "desired quality culture".
-
Wockhardt's Ex-Executive Barred From Securities Market For 6-Months For Insider Trading
Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules.
-
Wockhardt Reports Rs 207 Crore Loss In Q2 After Restructuring Its US Business
Wockhardt Ltd on Friday reported a consolidated loss after tax of Rs 207 crore in the second quarter ended September 30, 2022
-
UK Extends COVID-19 Vaccine Supply Deal With India's Wockhardt: Report
The United Kingdom has extended a deal with Wockhardt Ltd for the supply of COVID-19 vaccines by six months, the drugmaker said on Wednesday.
-
Wockhardt To Supply Millions Of Doses Of COVID-19 Vaccines To UK
Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Surges 5% As US Drug Regulator Excludes Drug From Import Alert
Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.
-
Expanding Markets, Launching New Products For Growth: Wockhardt
Wockhardt Ltd has said it is increasing investments in R&D, looking at expanding markets and launching new products to accelerate growth.
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal
The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.
-
Finance Ministry Looks To Expedite Clearances To FDI Proposals
Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).
-
Wockhardt Posts Over 82% Fall in Q3 Profit
Pharmaceuticals major WockhardtLtd on Thursday reported an 82.44 per cent decline in consolidatednet profit at Rs 60.97 crore for the fiscal third quarter that ended onDecember 31, 2015.
-
Wockhardt Slumps After US Regulator's Criticism of New Drug Plant
Drug maker Wockhardt Ltd said the US Food and Drug Administration (FDA) had issued a notice outlining manufacturing violations at its Shendra plant in western India, delaying the company's plans to rebuild its battered US business.
-
Allegiant Health Recalls Wockhardt's Heartburn Drug in US
According to the Enforcement Report for the week of June 24, 2015, the US health regulator has said 86,106 cartons of over-the-counter (OTC) Famotidine tablets USP of 20 mg are being voluntarily recalled by Allegiant Health.
-
Wockhardt to Recall Some India-Made Drugs Post-FDA Concerns
Generic drug maker Wockhardt Ltd on Tuesday said it would recall some drugs manufactured at its two plants in India before the US Food and Drug Administration (FDA) banned those sites due to quality concerns.
-
US Regulator Found No Issues With Maharashtra Plant: Wockhardt
Drug maker Wockhardt Ltd on Wednesday said the US Food and Drug Administration (FDA) has not found any issues with respect to data security and control measures at Chikalthana plant in a recent inspection, but suggested continuous voluntary compliance for "desired quality culture".
